Xiaojian Zhang

5.4k total citations · 1 hit paper
195 papers, 4.0k citations indexed

About

Xiaojian Zhang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Xiaojian Zhang has authored 195 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 25 papers in Oncology and 25 papers in Pharmacology. Recurrent topics in Xiaojian Zhang's work include Enzyme Catalysis and Immobilization (15 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Xiaojian Zhang is often cited by papers focused on Enzyme Catalysis and Immobilization (15 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Xiaojian Zhang collaborates with scholars based in China, United States and Singapore. Xiaojian Zhang's co-authors include Jingli Lü, Zhi‐Qiang Liu, Yu‐Guo Zheng, Xin Tian, Wei Han, Jing Yang, Jian Kang, Haiyang Meng, Weiyan Cheng and Quancheng Kan and has published in prestigious journals such as Advanced Functional Materials, Bioresource Technology and Chemical Communications.

In The Last Decade

Xiaojian Zhang

185 papers receiving 4.0k citations

Hit Papers

Aberrant m5C hypermethylation mediates intrinsic resistan... 2023 2026 2024 2025 2023 40 80 120

Peers

Xiaojian Zhang
Sang Kyum Kim South Korea
Hua Yu China
Jian Ni China
Yue Zhou China
Xiaojian Zhang
Citations per year, relative to Xiaojian Zhang Xiaojian Zhang (= 1×) peers Fahad A. Al‐Abbasi

Countries citing papers authored by Xiaojian Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaojian Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Zhang more than expected).

Fields of papers citing papers by Xiaojian Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojian Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Zhang. The network helps show where Xiaojian Zhang may publish in the future.

Co-authorship network of co-authors of Xiaojian Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Zhang. A scholar is included among the top collaborators of Xiaojian Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Zhang. Xiaojian Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Wei, Haoran Tang, Xiaojian Zhang, et al.. (2025). High-Performance n-Type Conducting Polymer-Based Supercapacitors with Enhanced Capacitance and Stability via Redox Additives. ACS Applied Materials & Interfaces. 17(51). 69754–69764.
2.
Li, Xiangyang, et al.. (2024). A Highly Stereoselective and Efficient Biocatalytic Synthesis of Chiral Syn-Aryl β-Hydroxy α-Amino Esters. ACS Catalysis. 14(20). 15374–15385. 8 indexed citations
3.
Du, Chao, Chu Chu, Xiaoli Ren, et al.. (2024). Identification and quantification of goat milk adulteration using mid-infrared spectroscopy and chemometrics. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 324. 124969–124969. 5 indexed citations
4.
5.
Cheng, Weiyan, Shasha Li, Suhua Wang, et al.. (2023). Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands. Bioorganic & Medicinal Chemistry. 82. 117237–117237. 19 indexed citations
6.
Shi, Yingying, Zhuolun Li, Qiuzheng Du, et al.. (2023). UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib. Scientific Reports. 13(1). 8044–8044. 2 indexed citations
7.
Xiong, Xianrong, Xixi Fei, Yan Xiong, et al.. (2023). Testis-specific knockout of Kdm2a reveals nonessential roles in male fertility but partially compromises spermatogenesis. Theriogenology. 209. 9–20. 7 indexed citations
8.
Zhang, Xiaojian, Chao Feng, Zeyu Fan, et al.. (2023). Stable seawater oxidation with a self-healing oxygen-evolving catalyst. Inorganic Chemistry Frontiers. 10(10). 3103–3111. 22 indexed citations
9.
Du, Qiuzheng, Na Li, Ziwei Jing, et al.. (2023). A multifunctional composite hydrogel promotes treatment of bisphosphonate-related osteonecrosis of the jaws. Applied Materials Today. 32. 101787–101787. 4 indexed citations
10.
Wang, Yueqin, Jingyao Wei, Ouwen Li, et al.. (2023). Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Molecular Cancer. 22(1). 81–81. 121 indexed citations breakdown →
11.
Xiong, Xianrong, Xiaojian Zhang, Daoliang Lan, et al.. (2022). Oocyte-Specific Knockout of Histone Lysine Demethylase KDM2a Compromises Fertility by Blocking the Development of Follicles and Oocytes. International Journal of Molecular Sciences. 23(19). 12008–12008. 9 indexed citations
12.
Jia, Xuedong, Xiaojuan Wang, Jie Hao, et al.. (2022). Psychological distress of frontline healthcare workers in the intensive care unit during the early stage of the COVID-19 pandemic: a qualitative study from China. BMJ Open. 12(2). e049627–e049627. 9 indexed citations
13.
Yang, Zhiheng, et al.. (2020). Iridium‐Catalysed Reductive Deoxygenation of Ketones with Formic Acid as Traceless Hydride Donor. Advanced Synthesis & Catalysis. 362(23). 5496–5505. 23 indexed citations
14.
Wang, Peile, et al.. (2020). Tacrolimus Starting Dose Prediction Based on Genetic Polymorphisms and Clinical Factors in Chinese Renal Transplant Recipients. Genetic Testing and Molecular Biomarkers. 24(10). 665–673. 10 indexed citations
15.
Pan, Hong, et al.. (2019). miR-4429 Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting CDK6 in Clear Cell Renal Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 34(5). 334–341. 18 indexed citations
16.
Li, Ying, Yilin Yang, Yunpeng Zhao, et al.. (2018). Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II. Free Radical Biology and Medicine. 131. 251–263. 60 indexed citations
17.
Kong, Xiang-Zhen, Zhi Sun, Lihua Zuo, et al.. (2016). Regulation of aerobic glycolysis by long non-coding RNAs in cancer. Biochemical and Biophysical Research Communications. 479(1). 28–32. 19 indexed citations
18.
Cheng, Weiyan, Jianhua Zhou, Xin Tian, & Xiaojian Zhang. (2016). Development of the Third Generation EGFR Tyrosine Kinase Inhibitors for Anticancer Therapy. Current Medicinal Chemistry. 23(29). 3343–3359. 12 indexed citations
19.
Kang, Jian, Ling Zhu, Jingli Lü, & Xiaojian Zhang. (2015). Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology. Journal of Neuroimmunology. 279. 25–32. 60 indexed citations
20.
Xu, Hao, Xiaojian Zhang, Xiaodong Zhu, et al.. (2013). Biomechanical Comparison of Transforaminal Lumbar Interbody Fusion With 1 or 2 Cages by Finite-Element Analysis. Operative Neurosurgery. 73(2 Suppl Operative). ons198–ons205. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026